Stockreport

Lyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital

Lyra Therapeutics, Inc.  (LYRA) 
PDF WATERTOWN, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), today announced that it is advancing its goal to p [Read more]